Ginkgo Bioworks Hldgs Inc (DNA) Stock Price, Quote & News

Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, developm...

Industry: Biotechnology

Sector: Healthcare

Phone: 877 422 5362

Website: www.ginkgo.bio

Address:

27 Drydock Avenue, 8th Floor, Boston, United States

jaydilks Jan. 9 at 1:23 PM

$DNA Almost everyone has given up on DNA. Since April of 2025, there’s a really nice bottom trendline. Higher Lows. I believe we are ready for a reversion to the Mean, zooming out a few years. Up 100% is closer to the Mean. This is where the reverse split pays for itself. There aren’t very many shares available in the market. Soon

0 · Reply

Georgii Jan. 9 at 10:05 AM

$DNA

0 · Reply

Bullish_Batman Jan. 9 at 1:48 AM

$DNA $15-$20 next week during JPM!

1 · Reply

madnessofcrowds Jan. 8 at 8:35 PM

$DNA look a the volume today lol

0 · Reply

madnessofcrowds Jan. 8 at 8:21 PM

$DNA grabbed a bit more 9.15

0 · Reply

PolishAssassin__ Jan. 8 at 5:50 PM

$DNA lost the battle? Huh, another 3 day signal starting to work Dont forget ENVX BBBY DNA all trade together and BBBY really starting to push (had fresh day3 few days ago) What, you scared to come on X and chat Frankie my boy?

0 · Reply

Georgii Jan. 7 at 7:50 PM

$DNA

0 · Reply

PolishAssassin__ Jan. 7 at 6:09 PM

$DNA I think I'll pass on anything you say in DNA I'll stick to trading it off fresh 3 day signals after a cabal walkdown Btw, you said DNA would be below $7 by now?😂🤦‍♂️🤡

1 · Reply

PolishAssassin__ Jan. 7 at 5:26 PM

$DNA running my mouth?😂 Working nicely off recent 3 day signal Speaking of running ones mouth, I thought you said DNA would be under $7 by now? Watch and learn my little DNA troll

1 · Reply

jaydilks Jan. 7 at 4:12 PM

$DNA Cool view of them testing a machine. https://x.com/ginkgo/status/2008922613943353851?s=61

0 · Reply

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Dec 17, 2025, 8:00 AM EST - 23 days ago

Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

Dec 11, 2025, 8:46 AM EST - 4 weeks ago

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies

Dec 9, 2025, 8:00 AM EST - 4 weeks ago

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

Dec 5, 2025, 8:33 AM EST - 4 weeks ago

Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

Dec 3, 2025, 8:00 AM EST - 5 weeks ago

STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

Nov 18, 2025, 8:00 AM EST - 7 weeks ago

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Nov 11, 2025, 2:15 AM EST - 2 months ago

Ginkgo Bioworks: Not There Yet

Nov 6, 2025, 8:26 PM EST - 2 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 2 months ago

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 8:00 AM EST - 2 months ago

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

DCI

Oct 31, 2025, 8:00 AM EDT - 2 months ago

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Oct 30, 2025, 4:05 PM EDT - 2 months ago

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Oct 23, 2025, 8:00 AM EDT - 2 months ago

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Sep 4, 2025, 8:00 AM EDT - 4 months ago

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Aug 29, 2025, 4:05 PM EDT - 4 months ago

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Aug 20, 2025, 8:01 AM EDT - 5 months ago

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Aug 12, 2025, 8:01 AM EDT - 5 months ago

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Aug 11, 2025, 5:51 AM EDT - 5 months ago

Ginkgo Bioworks: Sell The Recent Rally

Aug 8, 2025, 3:16 AM EDT - 5 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 5:01 PM EDT - 5 months ago

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 8:01 AM EDT - 5 months ago

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Jul 30, 2025, 9:01 AM EDT - 5 months ago

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Jul 17, 2025, 9:01 AM EDT - 6 months ago

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

May 21, 2025, 4:05 PM EDT - 8 months ago

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

May 8, 2025, 8:00 AM EDT - 8 months ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

TWST

May 6, 2025, 9:19 PM EDT - 8 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript

May 6, 2025, 5:00 PM EDT - 8 months ago

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Apr 30, 2025, 9:00 AM EDT - 9 months ago

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Apr 29, 2025, 4:00 PM EDT - 9 months ago

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Apr 22, 2025, 9:00 AM EDT - 9 months ago

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Apr 10, 2025, 9:00 AM EDT - 9 months ago

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

DCI

Apr 3, 2025, 9:01 AM EDT - 10 months ago

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Feb 27, 2025, 10:29 AM EST - 11 months ago

Ginkgo Bioworks: Revenue Struggles Continue

Feb 27, 2025, 6:19 AM EST - 11 months ago

2025 Is Make Or Break For Ginkgo Bioworks

Feb 26, 2025, 8:10 AM EST - 11 months ago

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FLYW

Feb 25, 2025, 9:22 PM EST - 11 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 5:00 PM EST - 11 months ago

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 21, 2025, 9:00 AM EST - 11 months ago

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Feb 20, 2025, 8:01 AM EST - 11 months ago

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Feb 18, 2025, 8:00 AM EST - 11 months ago

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Feb 6, 2025, 8:01 AM EST - 1 year ago

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Jan 23, 2025, 8:01 AM EST - 1 year ago

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

Jan 21, 2025, 7:00 AM EST - 1 year ago

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Jan 13, 2025, 8:01 AM EST - 1 year ago

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Jan 9, 2025, 11:38 AM EST - 1 year ago

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Jan 9, 2025, 8:00 AM EST - 1 year ago

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 17, 2024, 8:11 AM EST - 1 year ago

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Nov 18, 2024, 10:36 AM EST - 1 year ago

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better

Nov 13, 2024, 8:36 AM EST - 1 year ago

Ginkgo Bioworks: Not Enough Progress

jaydilks Jan. 9 at 1:23 PM

0 · Reply

Georgii Jan. 9 at 10:05 AM

$DNA

0 · Reply

Bullish_Batman Jan. 9 at 1:48 AM

$DNA $15-$20 next week during JPM!

1 · Reply

madnessofcrowds Jan. 8 at 8:35 PM

$DNA look a the volume today lol

0 · Reply

madnessofcrowds Jan. 8 at 8:21 PM

$DNA grabbed a bit more 9.15

0 · Reply

PolishAssassin__ Jan. 8 at 5:50 PM

0 · Reply

Georgii Jan. 7 at 7:50 PM

$DNA

0 · Reply

PolishAssassin__ Jan. 7 at 6:09 PM

$DNA I think I'll pass on anything you say in DNA I'll stick to trading it off fresh 3 day signals after a cabal walkdown Btw, you said DNA would be below $7 by now?😂🤦‍♂️🤡

1 · Reply

PolishAssassin__ Jan. 7 at 5:26 PM

$DNA running my mouth?😂 Working nicely off recent 3 day signal Speaking of running ones mouth, I thought you said DNA would be under $7 by now? Watch and learn my little DNA troll

1 · Reply

jaydilks Jan. 7 at 4:12 PM

$DNA Cool view of them testing a machine. https://x.com/ginkgo/status/2008922613943353851?s=61

0 · Reply

PolishAssassin__ Jan. 7 at 2:35 PM

$DNA Frankie I thought you said DNA would be under $7 by now?🤦‍♂️

1 · Reply

Rusty_Shackelford2024 Jan. 7 at 1:40 AM

$DNA in for another 1K shares

1 · Reply

TheHowlingMadness Jan. 6 at 4:47 PM

$DNA This fuckin guy man. 🤦‍♂️

0 · Reply

PolishAssassin__ Jan. 6 at 4:20 PM

$DNA Got its fresh day 3 yesterday Entry plan the same yesterday 30-40%, build to full on dips over few days Set SL from avg...put out 4 GTC offers at set increments higher and wait The drawdown (short walkdown) is always the key in creating a fresh 3 day signal Pay attention @TheHowlingMadness

0 · Reply

Georgii Jan. 6 at 3:17 PM

$DNA

0 · Reply

madnessofcrowds Jan. 6 at 1:17 AM

$DNA okay I really need to stop buying. my position is way, way too large.

0 · Reply

Shaffin786 Jan. 6 at 1:09 AM

$DNA 💡 Growth Catalysts Strengths underlying a Yardeni-style thesis ✔ Ginkgo is highly aligned with biotech AI acceleration, using automation, robotics, and data analytics that scale with AI integration. ✔ Its technology and services “autonomous labs” and tools, could become integral infrastructure for a wide range of biotech customers. ✔ Potential for recurring revenues from platform tools, automation rigs and software. Biotech trends like automation, computational biology, and integrated AI workflows are widely cited as top sector drivers for 2026+.

0 · Reply

madnessofcrowds Jan. 5 at 3:08 PM

$DNA bought more

0 · Reply

Georgii Jan. 5 at 3:04 PM

$DNA Time to accumulate

0 · Reply

TheHowlingMadness Jan. 4 at 5:26 AM

$DNA 🥱. Chapter 11 in a yr or less bud. Jmo. 👊

1 · Reply

PolishAssassin__ Jan. 3 at 11:00 PM

$DNA @TheHowlingMadness geesh this post already aging poorly Monday is potential day 3 for DNA Im seeing $20+ in the next few months but as always will take my chop watch and learn (again )

1 · Reply

madnessofcrowds Jan. 2 at 9:24 PM

$DNA bought some Jan ‘27 $12 calls at the open

1 · Reply

Market Cap	582.27M
Revenue (ttm)	227.04M
Net Income (ttm)	-547.03M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-240.94%
Debt to Equity Ratio	0.00

Volume	654,900
Avg Vol	1,100,176
Day's Range	N/A - N/A
Shares Out	60.59M
Stochastic %K	59%
Beta	1.55
Analysts	Hold
Price Target	$10.67